Advertisement

Topics

Shionogi Announces U.S. Availability of Mulpleta® (Lusutrombopag) for the Treatment of ...

07:06 EDT 30 Aug 2018 | BioMedReports - Blog

Corporate Communications, Shionogi & Co., Ltd.
Telephone: +81-6-6209-7885
or
Shionogi Inc. U.S. Media
Lindsay Bohlander, +1 973-307-3718
Director
lindsay.bohlander@shionogi.com

Read more...

Original Article: Shionogi Announces U.S. Availability of Mulpleta® (Lusutrombopag) for the Treatment of ...

NEXT ARTICLE

More From BioPortfolio on "Shionogi Announces U.S. Availability of Mulpleta® (Lusutrombopag) for the Treatment of ..."

Advertisement
Quick Search
Advertisement
Advertisement